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M. Morrison, PhD,† P. Marteau, PhD,‡ J. Dore´, PhD,* and M. Leclerc, PhD*
Background: Recent studies suggest that gastrointestinal (GI)
microbes play a part in the pathogenesis of Crohn’s disease (CD).
Methods: Fecal samples were collected from 16 healthy individ-
uals and 16 CD patients (age- and sex-matched). The DNA
extracted from these samples were subjected to two different
methods of microbiome analysis. Speciﬁc bacterial groups were
quantiﬁed by real-time polymerase chain reaction (PCR) methods
using primers designed using a high-throughput in-house bioinfor-
matics pipeline. The same DNA extracts were also used to pro-
duce ﬂuorescently labeled cRNA amplicons to interrogate a
custom-designed phylogenetic microarray for intestinal bacteria.
Results: Even though the intersubject variability was high, differen-
ces in the fecal microbiomes of healthy and CD patients were detected.
Faecalibacterium prausnitzii and Escherichia coli were more repre-
sented in healthy and ileal CD patients, respectively. Additionally,
probes speciﬁc for Ruminococcus bromii, Oscillibacter valericigenes,
Biﬁdobacterium biﬁdum, and Eubacterium rectale produced stronger
hybridization signals with the DNA samples from healthy subjects.
Conversely, species overrepresented in CD patients were E. coli,
Enterococcus faecium, and species from the Proteobacteria not nor-
mally found in the healthy human GI tract. Furthermore, we detected
‘‘healthy speciﬁc’’ molecular species or operational taxonomic units
(OTUs) that are not closely related to any known species (Faecalibac-
terium, Subdoligranulum, and Oscillospora species), indicating that
the phylogenetic dysbiosis is broader than at strain or species level.
Conclusions: These two techniques of microbiome analysis provided
a statistically robust new picture of the dysbiosis in fecal microbiota
from ileal CD patients. Speciﬁcally, we identiﬁed a set of six species
discriminant for CD, which provides a preliminary diagnostic tool.
(Inﬂamm Bowel Dis 2011;17:185–192)
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C ohn’s disease (CD) is a multifactorial disease of thehuman digestive tract with a still unclear etiology. A
genome-wide association study recently highlighted more
than 30 distinct loci involved in CD pathogenesis.1 Most of
the human genes encountered in these human genomic loci
were components of the autophagy pathway and innate
immune system.1 However, host genetic predisposition
does not alone explain CD triggers, remission, and relapse.
Environmental factors such as smoking,2,3 appendectomy,4
or endogenous microbiota are also involved in the onset of
the disease. During the last decade, evidence implicating
the host microbiota in CD has accumulated and it is now
well established that changes in the gut microbiota are an
important environmental component of inﬂammatory bowel
diseases (IBDs).5 Recent studies using rodent models have
pinpointed the intricate dialog established between the host
and the gut microbiota to maintain a mutual environment
within the gut. For instance, Bouskra et al6 demonstrated
that the lymphoid tissue maturation and proliferation was
driven by commensal gut bacteria through the NOD1 innate
receptor. Additionally, the detection of enteric bacteria by
Paneth cells through a MyD88-mediated activation protected
host tissue against invasion by pathogenic and commensal
bacteria.7 Finally, Garrett et al8 reported the existence of a
communicable colitogenic microbiota shaped by T-bet cell
deﬁciency in mice which was able to reinduce colitis in a ge-
netically intact host. Taken together, these results indicate
that the gastrointestinal tract is a strikingly complex ecosys-
tem and its homeostasis requires ﬁnely balanced regulation
and crosstalk between host cells and the resident microbiota.
In humans, the gut microbiota is composed of trillions of
microorganisms exceeding by a factor of 10 the total number
of host cells,9 with several thousands of different species
detected.10 A number of strategies have been used to exam-
ine the role of the intestinal microbiota in CD initiation and/
or maintenance. First of all, the search for persistent patho-
genic agents led to the detection of both Mycobacterium
avium paratuberculosis (MAP)11 and the Escherichia coli
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AIEC pathovar12 as potential infectious agents. However,
these microorganisms are not always detected in CD
patients,5 suggesting other microbes might also play a role in
CD. The non a priori approach of studying the gastrointesti-
nal (GI) tract microbiota using DNA sequencing techniques
has enabled the recovery of microbial diversity without the
need for bacterial cultivation13,14 and has provided some
new links between gut microbiota composition and IBD.15
Dysbiosis, deﬁned as an imbalance of the gut microbial com-
munity,16 has since been characterized by an alteration in the
balance between the Bacteroidetes and Firmicutes phyla.15,17
More precisely, the microbiota of CD patients is character-
ized by a decreased diversity within the Clostridium leptum
group, with one species, Faecalibacterium prausnitzii,
described as antiinﬂammatory.18 In addition, increased num-
bers of the Proteobacteria and Actinobacteria phyla have
also been observed in these molecular inventories.10 How-
ever, there is a need to develop a ﬁner resolution characteri-
zation of the gut microbiota in CD patients for a more pre-
cise measurement of health and disease.
The aim of this study was to provide new insights into
CD-associated dysbiosis by combining molecular approaches
through a ‘‘global strategy.’’ First, a bioinformatics approach
was developed and applied to investigate, without a priori, the
existing microbial 16S rRNA gene (rrs) molecular inventories
produced from earlier case–control studies of CD. The in sil-
ico predictions were then validated using real time quantita-
tive polymerase chain reaction (RT Q-PCR) to quantify these
molecular species in fecal DNA samples from a well-charac-
terized cohort of age- and sex-matched ileal CD patients and
healthy volunteers. The RT Q-PCR results were further vali-
dated and augmented using a custom-designed phylogenetic
microarray for intestinal bacteria.
MATERIALS AND METHODS
Subjects and Samples
With laboratory molecular studies used to perform the in
silico predictions and validation steps, a total of 54 subjects were
included (Table 1) comprising 24 CD and 30 healthy individuals.
The 16 CD patients used as the CD control group (CCG) were
part of a previously published double-blind controlled trial.19
These patients suffered from ileal CD requiring surgery ileal or
ileocecal resection. The healthy control group (HCG) was com-
posed of 16 individuals selected for both age and sex ratio con-
cordance with the CCG. Fecal samples were handled and DNA
extracted as previously described.17 All DNA samples were
checked by agarose gel electrophoresis (1% w/v) stained with
ethidium bromide, and also quantiﬁed using a Nanodrop ND-
1000 spectrophotometer (Labtech, Palaiseau, France).
Sequence Datasets
A total of 3302 sequences recovered from four differ-
ent rrs gene libraries produced by our group were ana-
lyzed, two of which were metagenomic and previously
TABLE 1. From Sequencing to Validation: Characteristics of the Subjects Included in the Study
Laboratory 16S rDNA Molecular Inventories Phylogenetic Speciﬁties Validation
CPLII ESL CPL* HSL* CD Control Group Healthy Control Group
n 2 8 6 6 16 16
Clinical status CD Healthy CD Healthy CD Healthy
Female 2 4 2 5 8 8
Mean age (SD) 37 (29–45) 78 (70–87) 30 (18–44) 32 (24–43) 31 (25–39) 30 (25–35)
Surgery — — —
Disease location:
Duodenum — 1 — 0 —
Ileum — 6 — 16 —
Colon — 4 — 0 —
Anal — 2 — 0 —
Treatment:
Aminosalicylates — 2 — NA —
Noninclusion criteria
Pregnancy
Colic resection
Antibiotherapy
Intestinal resection in the 5 later years
SD, standard deviation.
*Samples from these subjects were also used for phylogenetic microarrays validation (Ref. 27).
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published.15 The other two libraries were obtained by PCR
ampliﬁcation of rrs genes using DNA from the Elderly
Subject Library (ESL) and the CD Patient Library II
(CPLII) as templates. The sequence data produced from
these two sources are publicly available (Supporting Table
1). We also included 45,076 rrs gene sequences recovered
from nine libraries produced by other investigators studying
IBD, and deposited with the NCBI database prior to
November 2007.
rrs Gene Sequence Analysis and Phylogenetic
(OTU) Specificity Searches
A two-stage strategy was used for the in silico analy-
sis of the rrs gene sequences (Fig. 1). First, the four libra-
ries produced by our laboratory were analyzed to identify
speciﬁc operational taxonomic units (OTUs) either associ-
ated with the ‘‘CD’’ or ‘‘healthy’’ datasets, or shared.
Sequences were aligned using the MAFFT program20 and
distance matrices were computed with the DNADIST pro-
gram. Chimeras and sequence anomalies were removed
using the Mallard program.21 An OTU was deﬁned as
sequences sharing at least 98% similarity. OTU detection
and ecological estimates were determined using the
DOTUR program.22 OTUs were taxonomically assigned
with Sequence Match application (RDP-II, release 9). The
genetic diversity of CD patients and healthy subject libra-
ries were compared using SONS program, enabling the in-
ference of CD speciﬁcities.23 A CD speciﬁcity was deﬁned
based on OTU sequences preferentially retrieved in either
healthy or CD libraries or common to both. Then CD spe-
ciﬁcities were reﬁned by measuring, by BLASTN analysis,
their prevalence in nine 16S rDNA sequences libraries
from external datasets (Supporting Table 1). The resulting
selected OTU sequences were ﬁnally used for RT Q-PCR
primers design using the PRISE program24 (Table 2).
These OTUs were then searched for within the datasets
downloaded from NCBI (Supporting Table 1). Conven-
tional PCR and RT Q-PCR were then used to assess the
detection rate of each candidate OTU among the 32 DNA
samples (Table 1). Those OTUs either not detected in the
DNA samples or with no correlation with subject status
were withdrawn as uninformative. On the basis of this
analysis, six informative OTUs were identiﬁed.
Primer Specificity and PCR-based Assays
Primer speciﬁcities were assessed using Probe-
Check25 and tested by RT Q-PCR on fosmid/plasmid from
which the sequence originated, as well as cloned rrs gene
amplicons produced from the cultured type strains. PCR
was carried out using a PTC-100 thermocycler (MJ
Research, Reno, NV) with HotStarTaq Master Mix (Qia-
gen, Courtaboeuf, France), following the conditions: 95C
FIGURE 1. 1) CD and healthy 16S rRNA gene libraries from our laboratory datasets were analyzed by a phylogenetic
approach. OTUs sequences retrieved from healthy or CD libraries or common to both were selected. 2) CD speciﬁcities
sequences were then compared to nine external 16S rRNA gene libraries and a second round of OTU selection was applied.
3) Candidate OTUs were validated on 16 CD and 16 healthy fecal DNA samples using PCR and RT PCR. 4) In parallel, in the
same samples, a phylogenetic microarray approach was applied to validate CD speciﬁcities and analyze the microbial com-
munity structure of CD microbiota.
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for 10 minutes and 25 cycles of ampliﬁcation (95C for 15
sec, 60C for 1 min, 72C for 30 sec) followed by a ﬁnal
elongation step at 72C for 10 minutes. The RT Q-PCR
was carried out as previously described26 using an ABI
Prism 7700 (Applied Biosystems, Courtaboeuf, France)
using SYBR Green Master Mix (Applied Biosystems). The
results for the RT Q-PCR primer speciﬁcity tests for uncul-
tured Subdoligranulum sp. (OTUc03), Parabacteroides
distasonis, (OTUh06), Ruminococcus bromii (OTUe10),
Oscillibacter valericigenes (OTUa08), Bacteroides vulgatus
(OTUa05), E. coli (OTUe11) are shown in Supporting
Table 2.
Bacterial Strains, Fosmids/Plasmids-bearing E. coli
DH10B, Culture Conditions, and DNA Extraction
The anaerobic and aerobic bacterial strains used
were: P. distasonis DSM20701T, Fusobacterium nucleatum
DSM19508T, Fusobacterium naviforme DSM20699, Prevo-
tella copri 18205T, Prevotella ruminicola ATCC19189T,
O. valericigenes DSM18026T, Ruminococcus bromii
51896T, B. vulgatus ATCC8482, E. coli UEPSD S123 and
DH10B. Detailed culture media and growth conditions are
provided in the supplemental information data (Supporting
Text).
Microarray
The 32 DNA samples were also used to prepare ﬂuo-
rescently labeled cRNA fragments of the rrs gene that
were hybridized to a custom-designed phylogenetic micro-
array. A previous description and validation of the microar-
ray are reported in Kang et al.27
Statistical Analysis
The chi-square test was used to test selected OTU in-
dependence toward CD status. All statistics were computed
using R software and both ade428 and MADE429 packages.
A principal coordinate analysis (PCA) was performed on
the full distance matrix to map the overall genetic diversity
retrieved in the laboratory dataset and point out CD specif-
icities. A strip chart plot was performed on RT Q-PCR
data to map CD and healthy microbiotas according to CD
speciﬁcities. Medians were computed for each group using
OTU Cycle threshold (Ct) values, and Wilcoxon’s test was
applied to RT Q-PCR data to assess signiﬁcant differences
between CD and healthy groups. Similarity between micro-
biotas according to their microarray proﬁles was assessed
by a correspondence analysis (CoA). A ‘‘between-class’’
analysis was applied on the whole CoA dataset. A heatplot
map of the ﬁrst coordinate between class analysis was pro-
jected to highlight discriminating probes between healthy
versus CD groups.
RESULTS
CD Microbiota Imbalances Revealed
The in silico analyses identiﬁed a CD speciﬁcity,
deﬁned as an OTU preferentially retrieved in either healthy
or CD libraries, or common to both. These OTUs are asso-
ciated with uncultured Subdoligranulum sp. (OTUc03),
P. distasonis (OTUh06), R. bromii (OTUe10), O. valerici-
genes (OTUa08), B. vulgatus (OTUa05), and E. coli
(OTUe11; Supporting Table 2; Supporting Fig. 1). Except
for OTUc03, the OTU sequences were 99% similar to the
16S rrs gene sequence of the closest strain.
The OTUs found to be most depleted in CD patients
(Fig. 2) by both in silico and the RT Q-PCR analyses
belonged principally to the C. leptum group and to a lesser
extent within the Bacteroidetes phylum. Although the
‘‘unknown’’ OTUc03 was detected in most of the fecal sam-
ples (68.75% and 100% of CD and HCG, respectively) the
TABLE 2. Primer Sets Used in the Study
Target OTU Primer 50-30 Sequence Sources
OTUc03 hc03-F CTCCTGTCGTTAGGGACGATA This study
hc03-R TCTGCACTACTCAAGGCCAG
OTUh06 ch06-F GGTAAAGCTGAGGACTCTGGTGG This study
ch06-R GTGGTTTGGGGATTCGCTC
OTUe10 he10-F GGTCTTGACATCCAACTAACGAAGT This study
he10-R TTTTGTCAACGGCAGTCCTAT
OTUa08 ha08-F TCTTTTGTCAGGGACGAGTAGAA This study
ha08-R GCCTCTCCGATACTCAAGAAGAGT
OTUa05 B. vulg 01 CCCGGGCTTAAATTGCAGA Furet et al (26)
B. vulg 02 GCGGGACCTGTTAGTAACTGACAA
OTUe11 E. coli F CATGCCGCGTGTATGAAGAA Huijsdens et al (34)
E. coli R CGGGTAACGTCAATGAGCAAA
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RT Q-PCR analyses showed bacteria assigned to this OTU
were present in signiﬁcantly greater abundance in HCG than
in CCG patients (DCt ¼ 17.48; P < 0.001) (Fig. 2). The
R. bromii OTUe10 was also detected in most of the samples
(75% of CCG and 100% of HCG samples) but RT Q-PCR
suggested that these bacteria were more abundant in the
HCG than CCG group (DCt ¼ 13,56; P < 0.001). However,
the most striking difference was observed for O. valerici-
genes (OTUa08), which was detected in only 12.5% of the
CCG patients but in almost all (93.75%) of the HCG
patients. Additionally, its abundance was signiﬁcantly higher
in healthy than in CCG (DCt ¼ 17.33, P < 0.001) (Fig. 2).
Based on the in silico predictions and RT Q-PCR data,
P. distasonis (OTUh06) was detected in all 32 samples, but
the abundance of bacteria assigned to this OTU was signiﬁ-
cantly higher in the healthy than in the CCG (DCt ¼ 10.07;
P < 0.05). The B. vulgatus OTU (a05) was detected in most
of the fecal samples (81.25% of CCG and in 93.75% of HCG
groups), but the RT Q-PCR suggested there were no signiﬁ-
cant differences in the abundance of these bacteria between
the two groups (DCt ¼ 7.24, P > 0.05). Finally, the E. coli
OTU (e11) was detected in all 32 samples and there were no
signiﬁcant differences between the two groups in terms of its
abundance (DCt ¼ 5.32, P > 0.05).
Collectively, these results indicated that some commensal
gut bacterial inhabitants of healthy microbiota were depleted
from CD samples. Moreover, as previously shown, E. coli was
found to be overrepresented in some CD microbiota.
More Individual Variability in Microbiota from
Patients with Active CD than in Healthy
Individuals
The RT Q-PCR analyses suggested that in addition to
the differences outlined above, the CD patients showed a
greater degree of variance in the abundance of these OTUs,
compared to healthy individuals (Fig. 3), suggestive of
greater intraindividual variations among CD patients. The
chi-square test of the RT Q-PCR median distributions vali-
dated the observed topology, and indicated that all selected
OTUs were not independent of the clinical status of the
individuals. According to both PCA axes 1 and 2, which
accounted for 71.48% of the variance, the fecal microbiota
in CD patients appeared more scattered than those in
healthy subjects. Interestingly, two fecal samples from
healthy subjects (H17 and H21) were dispersed and closer
to the CD datasets, while the fecal samples from two CD
FIGURE 2. Strip chart diagram plot of the detected Ct
obtained by RT Q-PCR targeting CD speciﬁcities in 32 DNA
samples. Full and open circles correspond to CD (n ¼ 16)
and healthy samples (n ¼ 16), respectively. Dashed and
solid lines are median values computed for healthy and CD
Ct data, respectively.
FIGURE 3. PCA was computed using the RT Q-PCR Ct values
obtained for the six candidate OTUs. The two ﬁrst compo-
nents (principal components 1 and 2) were plotted and rep-
resented 71.48% of whole inertia. Individual microbiota, CD
(black, n ¼ 16) and healthy (white, n ¼ 16) were scattered
according to their RT Q-PCR proﬁles (Fig. 2).
FIGURE 4. CoA was computed on the whole phylogenetic
microarray dataset and both CoA axes 1 and 2 were plotted
which corresponded to 60.85% of whole inertia. CD (black,
n ¼ 14) and healthy (white, n ¼ 16) microbiota were
mapped according to their phylogenetic proﬁles.
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patients (CD12 and CD22) appeared most similar to the
proﬁles obtained from healthy individuals. Such observa-
tions suggest that patients considered otherwise ‘‘healthy’’
or ‘‘diseased’’ might actually be developing a microbiota
that is ‘‘at risk’’ or ‘‘remedial’’ for CD, respectively.
Finally, based on the PCA axis 1, the sensibility and speci-
ﬁcity for detecting CD status were 93.75% and 87.5%,
respectively.
Microarrays Confirmed the Discrimination
Between CD and Healthy Microbiota
The same 32 fecal samples were used to produce ﬂu-
orescently labeled cRNA probes and hybridized to a phylo-
genetic microarray speciﬁc for gut bacteria.27 Correspon-
dence analysis of the microarray data showed a tightly
clustering schema for the proﬁles produced from most of
the samples from healthy microbiota when PCA axes 1 and
2, accounting for 60.85% of the variance, were considered
(Fig. 4). Conversely, the samples from most of the CD
patients demonstrated a large distribution spectrum, which
was in accordance with RT Q-PCR data. Similarly, it was
noticeable that samples H17 and H21 from HCG were
again closest to the CD samples and CD12 and CD22 sam-
ples were more closely associated with the healthy sam-
ples. Furthermore, the co-inertia analysis supported the co-
structure produced from both the RT Q-PCR and microar-
ray datasets (data not shown). Taken together, the healthy
individuals and the patients suffering from an ileal CD
were strongly discriminated according to their GI tract
microbiota composition. However, whatever the method
used the dysbiosis was not absolute.
Further Insights into CD Dysbiosis as Revealed by
Microarray Analysis
Although the in silico and RT Q-PCR data provided
insight into the ﬂuctuations and abundance of six bacterial
OTUs in healthy and CD patients, the microarray analyses
provided additional and new insights. The discriminating
probes, set as 5-fold different from the median between
HCG and CCG (Fig. 5) revealed that F. prausnitzii,
R. bromii, Eubacterium rectale, Ruminococcus albus, Biﬁ-
dobacterium biﬁdum, P. distasonis, and Alistipes putredinis
were more abundant in healthy than in CD microbiota.
Very consistently, the OTUs predicted by the in silico anal-
ysis (and validated by RT Q-PCR), such as R. bromii and
P. distasonis (Fig. 2), were also in greater abundance.
Although O. valericigenes was overrepresented in the HCG
it was not similarly identiﬁed by the microarray, probably
due to the stringent threshold we set for microarray statisti-
cal analysis. F. prausnitzii was not shown as statistically
discriminated by RT Q-PCR because the species diversity
was larger than an OTU (data not shown), as conﬁrmed by
the ﬁve probes highlighted in the microarray. Nevertheless,
F. prausnitzii was detected as a healthy speciﬁc species.
Furthermore, several OTUs that were identiﬁed by in silico
predictions, but not statistically supported by PCR data
(data not shown) were conﬁrmed by microarray as overre-
presented in healthy microbiota such as B. biﬁdum.
Overrepresented Species in CD Microbiota
Both the RT Q-PCR and microarray analyses showed
that E. coli was overrepresented in the CD samples. Fur-
thermore, other members of the Proteobacteria phylum,
including Proteus vulgaris and Enterobacter cowanii, were
also present in greater abundance in CD patients. In rela-
tion to Gram-positive bacteria, Enterococcus faecium spe-
cies appeared to be overrepresented in a subset of patients
and some patients were found to have a greater abundance
of Streptococcus spp.
DISCUSSION
This study conﬁrms recent data but also provides
new insights into the phylogenetic speciﬁcities of CD-asso-
ciated microbiota by combining bioinformatics predictions
with biological validation, via a combination of RT Q-PCR
and microarray approaches.
First, combination of RT Q-PCR targeting six human
gut commensal bacteria in healthy and diseased individuals
provided a preliminary diagnostic tool with both relevant
sensitivity (93.75%) and speciﬁcity (87.5%) for discriminat-
ing subjects according to their health status. Then, species
shown in this study as being ‘‘healthy speciﬁc’’ were also
part of the recently described human intestinal phylogenetic
core.30 These species were also identiﬁed by the in silico
analysis of data arising from non-European studies, and this
shows that the dominant and prevalent bacterial species asso-
ciated with healthy microbiota are likely universal. As such,
these species should be targeted to monitor ‘‘normal’’ human
GI tract health. Among the healthy microbiota, O. valerici-
genes was shown to be a very good phylogenetic marker of
clinical status in the cohort examined here. Recently, Biﬁdo-
bacterium longum and ‘‘Oscillospira sp.,’’ a genus close to
O. valericigenes, were shown to grow cooperatively; the
exopolysaccharides produced by B. longum were associated
with the increased abundance of ‘‘Oscillospira sp.’’ in the
human GI tract.31 Our study also conﬁrmed that F. prausnit-
zii, recently shown to produce antiinﬂammatory factors, was
present in lower abundance in CD.18,32 Furthermore another
member of the C. leptum group, R. bromii, was reduced in
subjects with inﬂammation.
The bacterial genomes for some members of this
‘‘healthy microbial core’’ are now being sequenced via the
Human Microbiome Project (http://www.hmpdacc.org/) and
the International Human Microbiome Consortium (http://
www.human-microbiome.org/), and this will certainly help
to better understand their functional role in the human GI
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tract. Such information will be critical to augment our
understanding of the roles of these bacteria in health and
disease. Despite these advances, many of the ‘‘core’’
microbes, their interactions and processes, and their role in
health (or disease initiation and progression) remain cryp-
tic. For instance, ‘‘healthy’’ bacterial structural components
such as pili, ﬂagella, and ﬁmbriae, as well as metabolites
and other gene products that might interact with human
immune receptors (e.g., Toll-like receptors, Nod-like recep-
tors), require better characterization. Dysbiosis in CD is
probably not due to a single species, and our present study
demonstrates the importance of a non a priori method
approach, since it provided new species linked to active
CD. For instance, OTUc03, which seems of interest, repre-
sents a species far from any sequence in the database and
should therefore be targeted by single-cell genomics.
Some of the healthy species were missing, but, con-
versely, other species were more prevalent in CD patients
microbiota. E. coli, as previously demonstrated, was over-
represented in CD patients.12 In addition, several species
from the Proteobacteria phylum were linked to the CD sta-
tus. Most of these species (Streptococcus spp., Enterococ-
cus spp., Staphylococcus spp., Legionella spp., Vibrio spp.,
and Proteus spp.) are known to be facultative anaerobes,
and it seems thus that the microbiota during active ileal
CD is adapted to a high redox potential.
The variability among CD patients appeared higher
than among healthy individuals, as reported in the litera-
ture.32 Such variability among CD patients might explain
why OTUs speciﬁc to CD status have been difﬁcult to
detect. A hypothesis is that individuals who are predis-
posed to CD are less able to regulate the microbial makeup
of their gut, leading to an unstable microbial population.
Moreover, the CD microbial proﬁles highlighted by our
data are consistent with the deleterious schema believed to
be caused by changes in antimicrobial peptide production
which result in the killing of B. vulgatus, E. coli, and
E. faecalis.33
This study focused on patients suffering from an
active ileal form of CD, which is of particular interest
FIGURE 5. A between-class analysis was computed on the CoA results from the whole dataset. A heat plot map was applied
on the discriminated probes retrieved from the ﬁrst coordinate of the between-class analysis. Red indicates high intensity
probes and corresponds to an overrepresentation of species in samples. Conversely, blue indicates an underrepresentation.
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because of its proximity to the Peyer patches and immune
cells. Because CD is a disease with different phenotypes in
terms of pathology and progression, host genetics and life-
style differences might explain the discrepancies between
results arising from different cross-sectional studies. Sev-
eral ongoing projects using high-throughput metagenomics
approaches (such as the EU-funded project METAHIT,
http://www.metahit.eu/) will allow deeper analyses that will
provide additional conﬁrmation of our in silico predictions.
These metagenomic datasets from CD patients will help
identify which bacterial genes are under- or overrepre-
sented during inﬂammation. Clinically, dysbiosis can be
studied further by a large screening of individuals by a fast
quantiﬁcation of the six OTUs we detected here as discrim-
inatory of CD status.
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